theory clinical_105_0
imports Main

begin

typedecl entity
typedecl event

consts
  Trastuzumab :: "entity ⇒ bool"
  HER2Domain :: "entity ⇒ bool"
  Bind :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  ExtracellularDomain :: "entity ⇒ bool"
  InhibitoryEffect :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  IntracellularDomain :: "entity ⇒ bool"
  Have :: "event ⇒ bool"
  HER2V777L :: "entity ⇒ bool"
  TyrosineKinaseDomain :: "entity ⇒ bool"
  LocatedIn :: "entity ⇒ entity ⇒ bool"
  Resistance :: "entity ⇒ bool"
  AntibodyTherapy :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Because trastuzumab binds to the HER2 extracellular domain, it may have no inhibitory effect on the HER2-activating mutation in the intracellular kinase domain. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. Trastuzumab x ∧ HER2Domain y ∧ Bind e1 ∧ Agent e1 x ∧ Patient e1 y ∧ ExtracellularDomain y ∧ InhibitoryEffect z ∧ Mutation y ∧ IntracellularDomain y ∧ Have e2 ∧ Agent e2 x ∧ Patient e2 z"

(* Explanation 2: The HER2 V777L mutation is located in the tyrosine kinase domain. *)
axiomatization where
  explanation_2: "∃x y. HER2V777L x ∧ Mutation x ∧ TyrosineKinaseDomain y ∧ LocatedIn x y"

(* Explanation 3: HER2 V777L may cause resistance to antibody therapy. *)
axiomatization where
  explanation_3: "∃x y z e. HER2V777L x ∧ Resistance y ∧ AntibodyTherapy z ∧ Cause e ∧ Agent e x ∧ Patient e y ∧ To y z"

theorem hypothesis:
  assumes asm: "HER2V777L x ∧ Trastuzumab y ∧ Mutation x ∧ IntracellularDomain x"
  (* Hypothesis: HER2 V777L may cause resistance to trastuzumab, as trastuzumab binds to the extracellular kinase domain, whereas the mutation is in the intracellular kinase domain. *)
  shows "∃x y z e1 e2. HER2V777L x ∧ Trastuzumab y ∧ Resistance z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 z ∧ To z y ∧ Bind e2 ∧ Agent e2 y ∧ Patient e2 z ∧ ExtracellularDomain z ∧ Mutation x ∧ IntracellularDomain x"
proof -
  (* From the premise, we have known information about HER2V777L, Trastuzumab, Mutation, and IntracellularDomain. *)
  from asm have "HER2V777L x ∧ Trastuzumab y ∧ Mutation x ∧ IntracellularDomain x" by force
  (* Explanation 2 provides that HER2 V777L mutation is located in the tyrosine kinase domain. *)
  (* Explanation 3 provides that HER2 V777L may cause resistance to antibody therapy. *)
  (* We can use the logical relation Implies(C, D) to infer that HER2 V777L causes resistance to antibody therapy. *)
  from explanation_2 and explanation_3 have "Resistance z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 z ∧ To z y" sledgehammer
  (* Explanation 1 provides that trastuzumab binds to the HER2 extracellular domain. *)
  (* We can use the logical relation Implies(A, B) to infer that trastuzumab has no inhibitory effect on the mutation in the intracellular domain. *)
  from explanation_1 have "Bind e2 ∧ Agent e2 y ∧ Patient e2 z ∧ ExtracellularDomain z" <ATP>
  (* Combining all the information, we can conclude the hypothesis. *)
  then show ?thesis <ATP>
qed

end
